Furthermore, Torimoto et al. reported GLP1-mediated reduced postprandial triglyceride levels (TG) in human T2DM patients and therefore suggested indirect antiatherogenic effects of GLP1 [35]. This evidence concerns the gene GCG and type 2 diabetes mellitus.